Global Natural Killer Cell Therapy Market Size was estimated at USD 451.4 million in 2022 and is projected to reach USD 548.5 million by 2028, exhibiting a CAGR of 3.3% during the forecast period.
Global Natural Killer Cell Therapy Market Overview:
Global Natural Killer Cell Therapy Market Report 2022 comes with the extensive industry analysis development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Natural Killer Cell Therapy involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Natural Killer Cell Therapy Market
The Natural Killer Cell Therapy Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Natural Killer Cell Therapy Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Natural Killer Cell Therapy Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Natural Killer Cell Therapy Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Natural Killer Cell Therapy market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Natural Killer Cell Therapy Market Segmentation
Global Natural Killer Cell Therapy Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Natural Killer Cell Therapy market has been segmented into:
NK Cell Therapies
NK Cell Directed Antibodies
By Application, Natural Killer Cell Therapy market has been segmented into:
Cancer
Gastrointestinal Diseases
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Natural Killer Cell Therapy market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Natural Killer Cell Therapy market.
Top Key Players Covered in Natural Killer Cell Therapy market are:
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest
Objective to buy this Report:
1. Natural Killer Cell Therapy analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Natural Killer Cell Therapy market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction 1.1 Research Objectives 1.2 Research Methodology 1.3 Research Process 1.4 Scope and Coverage 1.4.1 Market Definition 1.4.2 Key Questions Answered 1.5 Market Segmentation Chapter 2:Executive Summary Chapter 3:Growth Opportunities By Segment 3.1 By Type 3.2 By Application Chapter 4: Market Landscape 4.1 Porter's Five Forces Analysis 4.1.1 Bargaining Power of Supplier 4.1.2 Threat of New Entrants 4.1.3 Threat of Substitutes 4.1.4 Competitive Rivalry 4.1.5 Bargaining Power Among Buyers 4.2 Industry Value Chain Analysis 4.3 Market Dynamics 4.3.1 Drivers 4.3.2 Restraints 4.3.3 Opportunities 4.5.4 Challenges 4.4 Pestle Analysis 4.5 Technological Roadmap 4.6 Regulatory Landscape 4.7 SWOT Analysis 4.8 Price Trend Analysis 4.9 Patent Analysis 4.10 Analysis of the Impact of Covid-19 4.10.1 Impact on the Overall Market 4.10.2 Impact on the Supply Chain 4.10.3 Impact on the Key Manufacturers 4.10.4 Impact on the Pricing Chapter 5: Natural Killer Cell Therapy Market by Type 5.1 Natural Killer Cell Therapy Market Overview Snapshot and Growth Engine 5.2 Natural Killer Cell Therapy Market Overview 5.3 NK Cell Therapies 5.3.1 Introduction and Market Overview 5.3.2 Historic and Forecasted Market Size (2016-2028F) 5.3.3 Key Market Trends, Growth Factors and Opportunities 5.3.4 NK Cell Therapies: Geographic Segmentation 5.4 NK Cell Directed Antibodies 5.4.1 Introduction and Market Overview 5.4.2 Historic and Forecasted Market Size (2016-2028F) 5.4.3 Key Market Trends, Growth Factors and Opportunities 5.4.4 NK Cell Directed Antibodies: Geographic Segmentation Chapter 6: Natural Killer Cell Therapy Market by Application 6.1 Natural Killer Cell Therapy Market Overview Snapshot and Growth Engine 6.2 Natural Killer Cell Therapy Market Overview 6.3 Cancer 6.3.1 Introduction and Market Overview 6.3.2 Historic and Forecasted Market Size (2016-2028F) 6.3.3 Key Market Trends, Growth Factors and Opportunities 6.3.4 Cancer: Geographic Segmentation 6.4 Gastrointestinal Diseases 6.4.1 Introduction and Market Overview 6.4.2 Historic and Forecasted Market Size (2016-2028F) 6.4.3 Key Market Trends, Growth Factors and Opportunities 6.4.4 Gastrointestinal Diseases: Geographic Segmentation 6.5 Others 6.5.1 Introduction and Market Overview 6.5.2 Historic and Forecasted Market Size (2016-2028F) 6.5.3 Key Market Trends, Growth Factors and Opportunities 6.5.4 Others: Geographic Segmentation Chapter 7: Company Profiles and Competitive Analysis 7.1 Competitive Landscape 7.1.1 Competitive Positioning 7.1.2 Natural Killer Cell Therapy Sales and Market Share By Players 7.1.3 Industry BCG Matrix 7.1.4 Heat Map Analysis 7.1.5 Natural Killer Cell Therapy Industry Concentration Ratio (CR5 and HHI) 7.1.6 Top 5 Natural Killer Cell Therapy Players Market Share 7.1.7 Mergers and Acquisitions 7.1.8 Business Strategies By Top Players 7.2 NEKTAR THERAPEUTICS 7.2.1 Company Overview 7.2.2 Key Executives 7.2.3 Company Snapshot 7.2.4 Operating Business Segments 7.2.5 Product Portfolio 7.2.6 Business Performance 7.2.7 Key Strategic Moves and Recent Developments 7.2.8 SWOT Analysis 7.3 INNATE PHARMA SA 7.4 AFFIMED 7.5 CHIPSCREEN BIOSCIENCES 7.6 GLYCOSTEM THERAPEUTICS 7.7 FATE THERAPEUTICS 7.8 DRAGONFLY THERAPEUTICS 7.9 KIADIS PHARMA 7.10 NKARTA THERAPEUTICS 7.11 NANTKWEST Chapter 8: Global Natural Killer Cell Therapy Market Analysis, Insights and Forecast, 2016-2028 8.1 Market Overview 8.2 Historic and Forecasted Market Size By Type 8.2.1 NK Cell Therapies 8.2.2 NK Cell Directed Antibodies 8.3 Historic and Forecasted Market Size By Application 8.3.1 Cancer 8.3.2 Gastrointestinal Diseases 8.3.3 Others Chapter 9: North America Natural Killer Cell Therapy Market Analysis, Insights and Forecast, 2016-2028 9.1 Key Market Trends, Growth Factors and Opportunities 9.2 Impact of Covid-19 9.3 Key Players 9.4 Key Market Trends, Growth Factors and Opportunities 9.4 Historic and Forecasted Market Size By Type 9.4.1 NK Cell Therapies 9.4.2 NK Cell Directed Antibodies 9.5 Historic and Forecasted Market Size By Application 9.5.1 Cancer 9.5.2 Gastrointestinal Diseases 9.5.3 Others 9.6 Historic and Forecast Market Size by Country 9.6.1 U.S. 9.6.2 Canada 9.6.3 Mexico Chapter 10: Europe Natural Killer Cell Therapy Market Analysis, Insights and Forecast, 2016-2028 10.1 Key Market Trends, Growth Factors and Opportunities 10.2 Impact of Covid-19 10.3 Key Players 10.4 Key Market Trends, Growth Factors and Opportunities 10.4 Historic and Forecasted Market Size By Type 10.4.1 NK Cell Therapies 10.4.2 NK Cell Directed Antibodies 10.5 Historic and Forecasted Market Size By Application 10.5.1 Cancer 10.5.2 Gastrointestinal Diseases 10.5.3 Others 10.6 Historic and Forecast Market Size by Country 10.6.1 Germany 10.6.2 U.K. 10.6.3 France 10.6.4 Italy 10.6.5 Russia 10.6.6 Spain 10.6.7 Rest of Europe Chapter 11: Asia-Pacific Natural Killer Cell Therapy Market Analysis, Insights and Forecast, 2016-2028 11.1 Key Market Trends, Growth Factors and Opportunities 11.2 Impact of Covid-19 11.3 Key Players 11.4 Key Market Trends, Growth Factors and Opportunities 11.4 Historic and Forecasted Market Size By Type 11.4.1 NK Cell Therapies 11.4.2 NK Cell Directed Antibodies 11.5 Historic and Forecasted Market Size By Application 11.5.1 Cancer 11.5.2 Gastrointestinal Diseases 11.5.3 Others 11.6 Historic and Forecast Market Size by Country 11.6.1 China 11.6.2 India 11.6.3 Japan 11.6.4 Singapore 11.6.5 Australia 11.6.6 New Zealand 11.6.7 Rest of APAC Chapter 12: Middle East & Africa Natural Killer Cell Therapy Market Analysis, Insights and Forecast, 2016-2028 12.1 Key Market Trends, Growth Factors and Opportunities 12.2 Impact of Covid-19 12.3 Key Players 12.4 Key Market Trends, Growth Factors and Opportunities 12.4 Historic and Forecasted Market Size By Type 12.4.1 NK Cell Therapies 12.4.2 NK Cell Directed Antibodies 12.5 Historic and Forecasted Market Size By Application 12.5.1 Cancer 12.5.2 Gastrointestinal Diseases 12.5.3 Others 12.6 Historic and Forecast Market Size by Country 12.6.1 Turkey 12.6.2 Saudi Arabia 12.6.3 Iran 12.6.4 UAE 12.6.5 Africa 12.6.6 Rest of MEA Chapter 13: South America Natural Killer Cell Therapy Market Analysis, Insights and Forecast, 2016-2028 13.1 Key Market Trends, Growth Factors and Opportunities 13.2 Impact of Covid-19 13.3 Key Players 13.4 Key Market Trends, Growth Factors and Opportunities 13.4 Historic and Forecasted Market Size By Type 13.4.1 NK Cell Therapies 13.4.2 NK Cell Directed Antibodies 13.5 Historic and Forecasted Market Size By Application 13.5.1 Cancer 13.5.2 Gastrointestinal Diseases 13.5.3 Others 13.6 Historic and Forecast Market Size by Country 13.6.1 Brazil 13.6.2 Argentina 13.6.3 Rest of SA Chapter 14 Investment Analysis Chapter 15 Analyst Viewpoint and Conclusion
Publisher: Introspective Market Research
Related Reports
- Intrauterine Devices Market By Product Type (Hormonal Intrauterine Device and Copper Intrauterine Device), By Material (Plastic, Copper and Hormonal (Levonorgestrel)), By Age Group (15-24 years, 25-34 years, 35-44 years and Above 44 years), By End-user (Hospital, Gynecology Clinics, Community Health Care Centers and Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
- Arterial Thrombectomy Devices Market By Device Type (Aspiration Thrombectomy Devices, Mechanical Thrombectomy Devices, Rheolytic Thrombectomy Devices, Ultrasound-Assisted Thrombectomy Devices, Laser-Based Thrombectomy Devices, Others), By Application (Peripheral Arterial Disease (PAD), Coronary Artery Disease (CAD), Ischemic Stroke, Renal Artery Thrombosis, Acute limb Ischemia, Others), By End-user (Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Academic and Research Institutions), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
- Global Operating Room Infection Control Consumable Competitive Landscape Professional Research Report 2024
- Global Oral Fluid Drug Test System Competitive Landscape Professional Research Report 2024
- Global Orthopaedics Competitive Landscape Professional Research Report 2024
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support
Frequently Asked Questions (FAQ)
Global Natural Killer Cell Therapy Market Size was estimated at USD 451.4 million in 2022 and is projected to reach USD 548.5 million by 2028.
Nektar Therapeutics,Innate Pharma SA,Affimed,Chipscreen Biosciences,Glycostem Therapeutics,Fate Therapeutics,Dragonfly Therapeutics,Kiadis Pharma,Nkarta Therapeutics,NantKwest
North America,Europe,Asia-Pacific,South America,Middle East & Africa